These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28328286)

  • 1. Identification of the minimum effective dose for normally distributed data using a Bayesian variable selection approach.
    Otava M; Shkedy Z; Hothorn LA; Talloen W; Gerhard D; Kasim A
    J Biopharm Stat; 2017; 27(6):1073-1088. PubMed ID: 28328286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data.
    Shao K; Gift JS
    Risk Anal; 2014 Jan; 34(1):101-20. PubMed ID: 23758102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An empirical comparison of information-theoretic selection criteria for multivariate behavior genetic models.
    Markon KE; Krueger RF
    Behav Genet; 2004 Nov; 34(6):593-610. PubMed ID: 15520516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An objective Bayesian analysis of a crossover design via model selection and model averaging.
    Li D; Sivaganesan S
    Stat Med; 2016 Nov; 35(25):4509-4527. PubMed ID: 27364101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative performance of Bayesian and AIC-based measures of phylogenetic model uncertainty.
    Alfaro ME; Huelsenbeck JP
    Syst Biol; 2006 Feb; 55(1):89-96. PubMed ID: 16507526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model averaging for treatment effect estimation in subgroups.
    Bornkamp B; Ohlssen D; Magnusson BP; Schmidli H
    Pharm Stat; 2017 Mar; 16(2):133-142. PubMed ID: 27935199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of three methods for integrating historical information for Bayesian model averaged benchmark dose estimation.
    Shao K
    Environ Toxicol Pharmacol; 2012 Sep; 34(2):288-296. PubMed ID: 22647377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graphical tools for model selection in generalized linear models.
    Murray K; Heritier S; Müller S
    Stat Med; 2013 Nov; 32(25):4438-51. PubMed ID: 23716396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian model-averaged benchmark dose analysis via reparameterized quantal-response models.
    Fang Q; Piegorsch WW; Simmons SJ; Li X; Chen C; Wang Y
    Biometrics; 2015 Dec; 71(4):1168-75. PubMed ID: 26102570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The problem of model selection uncertainty in structural equation modeling.
    Preacher KJ; Merkle EC
    Psychol Methods; 2012 Mar; 17(1):1-14. PubMed ID: 22268762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian dose-response analysis for epidemiological studies with complex uncertainty in dose estimation.
    Kwon D; Hoffman FO; Moroz BE; Simon SL
    Stat Med; 2016 Feb; 35(3):399-423. PubMed ID: 26365692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian methods for uncertainty factor application for derivation of reference values.
    Simon TW; Zhu Y; Dourson ML; Beck NB
    Regul Toxicol Pharmacol; 2016 Oct; 80():9-24. PubMed ID: 27211295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Part 1. Statistical Learning Methods for the Effects of Multiple Air Pollution Constituents.
    Coull BA; Bobb JF; Wellenius GA; Kioumourtzoglou MA; Mittleman MA; Koutrakis P; Godleski JJ
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):5-50. PubMed ID: 26333238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the false negative fraction of a diagnostic kit through Bayesian regression model averaging.
    Ranyimbo AO; Held L
    Stat Med; 2006 Feb; 25(4):653-67. PubMed ID: 16158401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Part 2. Development of Enhanced Statistical Methods for Assessing Health Effects Associated with an Unknown Number of Major Sources of Multiple Air Pollutants.
    Park ES; Symanski E; Han D; Spiegelman C
    Res Rep Health Eff Inst; 2015 Jun; (183 Pt 1-2):51-113. PubMed ID: 26333239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential uncertainty reduction in model-averaged benchmark dose estimates informed by an additional dose study.
    Shao K; Small MJ
    Risk Anal; 2011 Oct; 31(10):1561-75. PubMed ID: 21388425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian approach for quantifying the uncertainty of neutron doses derived from spectrometric measurements.
    Reginatto M
    Radiat Prot Dosimetry; 2006; 121(1):64-9. PubMed ID: 16877470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoiding tipping points in fisheries management through Gaussian process dynamic programming.
    Boettiger C; Mangel M; Munch S
    Proc Biol Sci; 2015 Feb; 282(1801):20141631. PubMed ID: 25567644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian penalized log-likelihood ratio approach for dose response clinical trial studies.
    Tang Y; Cai C; Sun L; He J
    J Biopharm Stat; 2017; 27(6):975-989. PubMed ID: 28318420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical Bayesian formulations for selecting variables in regression models.
    Rockova V; Lesaffre E; Luime J; Löwenberg B
    Stat Med; 2012 May; 31(11-12):1221-37. PubMed ID: 22275239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.